World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
69
Citations
27483
World Ranking
1994
National Ranking
843

Theo Heller publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Theo Heller sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 261 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Theo Heller D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Theo Heller sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 69 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Theo Heller is affiliated with the National Institutes of Health in the United States and has a research portfolio focused primarily on medicine, with a significant emphasis on epidemiology, hepatology, surgery, genetics, and immunology. Their body of work encompasses a diverse range of topics related to liver disease diagnosis and treatment, hepatitis B and C virus research, immunodeficiency and autoimmune disorders, liver disease and transplantation, genetic factors in colorectal cancer, and Helicobacter pylori-related gastroenterology studies.

Their most frequent publication venues include:

  • Gastroenterology
  • Hepatology
  • The American Journal of Gastroenterology
  • Blood
  • Hepatology Communications

Among recent papers featuring their work are:

  • The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort, 2022, Frontiers in Immunology
  • Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1, 2021, JAMA Surgery
  • A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis, 2021, Hepatology
  • The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1, 2024, New England Journal of Medicine
  • Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome, 2022, Annals of the Rheumatic Diseases

Theo Heller frequently collaborates with researchers such as Christopher Koh, David E. Kleiner, Steven M. Holland, Jeremy L. Davis, and Anusha Vittal. These partnerships have contributed broadly to their extensive publication record and research output in the field of medicine.

Their main fields of study break down into several subfields reflecting the interdisciplinary nature of their research:

  • Epidemiology
  • Hepatology
  • Surgery
  • Genetics
  • Immunology

Core topics addressed in their research include:

  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Immunodeficiency and Autoimmune Disorders
  • Liver Disease and Transplantation
  • Genetic factors in colorectal cancer
  • Helicobacter pylori-related gastroenterology studies

Best Publications

  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

    Madan H. Jagasia;Hildegard T. Greinix;Mukta Arora;Kirsten M. Williams

  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

    Madan H. Jagasia;Hildegard T. Greinix;Mukta Arora;Kirsten M. Williams

  • A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.

    Kittichai Promrat;Glen Lutchman;Gabriel I. Uwaifo;Renee J. Freedman

  • Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4

    Hye Sun Kuehn;Weiming Ouyang;Bernice Lo;Elissa K. Deenick;Elissa K. Deenick

  • Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

    Qing Zhou;Dan Yang;Amanda K Ombrello;Andrey V Zavialov

  • Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.

    Austin G. Duffy;Susanna V. Ulahannan;Oxana Makorova-Rusher;Osama Rahma

  • Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

    Raymond T. Chung;Marc G. Ghany;Arthur Y. Kim;Kristen M. Marks

  • Residual NADPH oxidase and survival in chronic granulomatous disease.

    Douglas B. Kuhns;W. Gregory Alvord;Theo Heller;Jordan J. Feld

  • JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

    Gina A. Montealegre Sanchez;Adam L Reinhardt;Suzanne Ramsey;Helmut Wittkowski

  • Danazol Treatment for Telomere Diseases.

    Danielle M Townsley;Bogdan Dumitriu;Delong Liu;Angélique Biancotto

  • Common Severe Infections in Chronic Granulomatous Disease

    Beatriz E. Marciano;Christine Spalding;Alan Fitzgerald;Daphne Mann

  • Host Response to Translocated Microbial Products Predicts Outcomes of Patients With HBV or HCV Infection

    Netanya G. Sandler;Christopher Koh;Annelys Roque;Jason L. Eccleston

  • Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number.

    Jonathan J Lyons;Xiaomin Yu;Jason D Hughes;Quang T Le

  • Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C

    Alejandro Soza;James E. Everhart;Marc G. Ghany;Edward Doo

  • The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis.

    Glen Lutchman;Apurva Modi;David E. Kleiner;Kittichai Promrat

  • Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.

    Golo Ahlenstiel;Rachel H. Titerence;Christopher Koh;Birgit Edlich

  • Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

    Elise M.N. Ferre;Stacey R. Rose;Sergio D. Rosenzweig;Peter D. Burbelo

  • Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.

    Christopher Koh;Laetitia Canini;Laetitia Canini;Harel Dahari;Harel Dahari;Xiongce Zhao

  • Nodular regenerative hyperplasia: not all nodules are created equal.

    Preeti A. Reshamwala;David E. Kleiner;Theo Heller

  • Pathogenesis of hepatitis C-associated hepatocellular carcinoma.

    T. Jake Liang;Theo Heller

Frequent Co-Authors

David E. Kleiner
David E. Kleiner National Institutes of Health
Jay H. Hoofnagle
Jay H. Hoofnagle National Institutes of Health
T. Jake Liang
T. Jake Liang National Institutes of Health
Marc G. Ghany
Marc G. Ghany National Institutes of Health
Harry L. Malech
Harry L. Malech National Institutes of Health
Steven M. Holland
Steven M. Holland University of Georgia
Steven M. Holland
Steven M. Holland National Institute of Allergy and Infectious Diseases
Jeffrey S. Glenn
Jeffrey S. Glenn Stanford University
William A. Gahl
William A. Gahl National Institutes of Health
Barbara Rehermann
Barbara Rehermann National Institute of Diabetes and Digestive and Kidney Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various specialized fields, many of which offer flexible online education options. For those interested in health data and information systems, exploring the best online health information management degree cahiim accredited programs can be a strategic move. These degrees combine healthcare knowledge with technical skills, preparing students for roles in managing critical health information.

For quicker entry into the healthcare industry, pursuing the quickest medical billing and coding certificate online can be ideal. This pathway emphasizes the administrative side of medical services, a vital component supporting clinical microbiology work in healthcare settings.

If you're aiming to expand your medical expertise, it’s helpful to understand what medical degree can i get online options are available. While traditional medical degrees often require in-person attendance, emerging online programs provide more accessibility for healthcare professionals seeking to enhance their qualifications remotely.

Additionally, public health remains closely tied to microbiology careers. Many students benefit from exploring easy mph online programs to deepen their understanding of population health, epidemiology, and disease prevention, complementing their microbiology foundation.

Best Scientists Citing Theo Heller

Trending Scientists

Recently Published Articles